Arimidex

Arimidex is a brand name of anastrozole, approved by the FDA in the following formulation(s):

ARIMIDEX (anastrozole - tablet; oral)

• 
  Manufacturer: ASTRAZENECA
  
  Approval date: December 27, 1995
  
  Strength(s): 1MG ^[RLD][AB]

Has a generic version of Arimidex been approved?

A generic version of Arimidex has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Arimidex and have been approved by the FDA:

anastrozole tablet; oral

• 
  Manufacturer: ACCORD HLTHCARE INC
  
  Approval date: June 28, 2010
  
  Strength(s): 1MG ^[AB]


• 
  Manufacturer: DR REDDYS LABS LTD
  
  Approval date: June 28, 2010
  
  Strength(s): 1MG ^[AB]


• 
  Manufacturer: FRESENIUS KABI ONCOL
  
  Approval date: June 28, 2010
  
  Strength(s): 1MG ^[AB]


• 
  Manufacturer: KUDCO IRELAND
  
  Approval date: January 5, 2011
  
  Strength(s): 1MG ^[AB]


• 
  Manufacturer: MYLAN
  
  Approval date: June 28, 2010
  
  Strength(s): 1MG ^[AB]


• 
  Manufacturer: NATCO PHARMA LTD
  
  Approval date: June 28, 2010
  
  Strength(s): 1MG ^[AB]


• 
  Manufacturer: ROXANE
  
  Approval date: June 28, 2010
  
  Strength(s): 1MG ^[AB]


• 
  Manufacturer: SANDOZ
  
  Approval date: June 28, 2010
  
  Strength(s): 1MG ^[AB]


• 
  Manufacturer: SANTOS BIOTECH
  
  Approval date: June 28, 2010
  
  Strength(s): 1MG ^[AB]


• 
  Manufacturer: SUN PHARM INDS LTD
  
  Approval date: July 15, 2011
  
  Strength(s): 1MG ^[AB]


• 
  Manufacturer: TEVA PHARMS
  
  Approval date: June 28, 2010
  
  Strength(s): 1MG ^[AB]


• 
  Manufacturer: THREE RIVERS PHARMS
  
  Approval date: June 28, 2010
  
  Strength(s): 1MG ^[AB]


• 
  Manufacturer: WATSON LABS
  
  Approval date: June 28, 2010
  
  Strength(s): 1MG ^[AB]


• 
  Manufacturer: ZYDUS PHARMS USA INC
  
  Approval date: June 28, 2010
  
  Strength(s): 1MG ^[AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Arimidex. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Arimidex.

Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

• Exclusivity expiration dates:
  • December 5, 2011 - REVISIONS TO LABELING BASED ON DATA SUBMITTED IN RESPONSE TO PEDIATRIC WRITTEN REQUEST
  
  
  • June 5, 2012 - PEDIATRIC EXCLUSIVITY
  
  

See also...

• Arimidex Consumer Information (Drugs.com)
• Arimidex Consumer Information (Wolters Kluwer)
• Arimidex Consumer Information (Cerner Multum)
• Arimidex Advanced Consumer Information (Micromedex)
• Arimidex AHFS DI Monographs (ASHP)
• Anastrozole Consumer Information (Wolters Kluwer)
• Anastrozole Consumer Information (Cerner Multum)
• Anastrozole Advanced Consumer Information (Micromedex)
• Anastrozole AHFS DI Monographs (ASHP)